Search for: "Ikea US Retail LLC" Results 1 - 11 of 11
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Jan 2021, 6:46 am by Horwitz Horwitz & Associates
Ikea US Retail LLC is facing a proposed class action in Pennsylvania federal court alleging it carried out a "weak" recall of dressers that are prone to tipping over and have resulted in injuries to and deaths of children. [read post]
23 Jul 2010, 3:40 am by SHG
Copyright © 2010 Simple Justice NY LLC. [read post]
12 Jan 2016, 11:38 am by Lebowitz & Mzhen
In some cases, distributors, wholesalers, and retailers of a dangerous product may also be held liable. [read post]
21 May 2020, 8:47 am by Kristian Soltes
European Retailers Say Card Costs Rose After EU Capped FeesPaymentsSource – May 14, 2020 Retailers including Tesco Plc, Ikea and Amazon.com Inc. called on European Union regulators to crack down on credit and debit card fees that have increased after laws capped so-called interchange fees five years ago. [read post]
12 May 2011, 8:48 am by Rebecca Tushnet
Scripps Networks Interactive, LLC, 2011 WL 1750711 (W.D. [read post]
14 Apr 2010, 11:27 am by Stuart Blake
Preferences or other incentives could be given for “products manufactured using processes that minimize greenhouse gas emissions. [read post]
2 Dec 2011, 8:30 am by Jonathan Rosenfeld
The toys were sold at small retail stores na- tionwide, online at Toys R Us, Amazon.com and CSN on walmart.com from January 2007 through December 2009. [read post]
19 Aug 2011, 12:01 am by Marie Louise
(Patents Post Grant Blog)   US Patents Attacking 112 support in patent reexamination: CAFC’s NTP decisions (Patents Post Grant Blog)   US Patents – Decisions CAFC: If the software method is not patentable, then neither is the “computer readable medium”: Cybersource Corp. v Retail Decisions Inc. [read post]
28 Mar 2008, 6:00 am
- Anonymity of policy research group quoted on pharma patenting policy and stats: (Spicy IP),Thailand: More news/reactions on compulsory licenses: (Generic Pharmaceuticals & IP),US: Follow-on biologic drugs and patent law: A potential disconnect? [read post]